Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 91

1.

Google Search Trends in Oncology and the Impact of Celebrity Cancer Awareness.

Kaleem T, Malouff TD, Stross WC, Waddle MR, Miller DH, Seymour AL, Zaorsky NG, Miller RC, Trifiletti DM, Vallow L.

Cureus. 2019 Aug 10;11(8):e5360. doi: 10.7759/cureus.5360.

2.

Does the addition of chemotherapy to neoadjuvant radiotherapy impact survival in high-risk extremity/trunk soft-tissue sarcoma?

Chowdhary M, Chowdhary A, Sen N, Zaorsky NG, Patel KR, Wang D.

Cancer. 2019 Nov 1;125(21):3801-3809. doi: 10.1002/cncr.32386. Epub 2019 Sep 6.

PMID:
31490546
3.

Risk-adapted stereotactic body radiation therapy for central and ultra-central early-stage inoperable non-small cell lung cancer.

Meng MB, Wang HH, Zaorsky NG, Sun BS, Zhu L, Song YC, Li FT, Dong Y, Wang JS, Chen HM, Yu XY, Yuan ZY.

Cancer Sci. 2019 Aug 28. doi: 10.1111/cas.14185. [Epub ahead of print]

4.

Surgical excision, Mohs micrographic surgery, external-beam radiotherapy, or brachytherapy for indolent skin cancer: An international meta-analysis of 58 studies with 21,000 patients.

Lee CT, Lehrer EJ, Aphale A, Lango M, Galloway TJ, Zaorsky NG.

Cancer. 2019 Oct 15;125(20):3582-3594. doi: 10.1002/cncr.32371. Epub 2019 Jul 29.

PMID:
31355928
5.

Exceptional Responders in Oncology: A Systematic Review and Meta-Analysis of Patient Level Data.

Cummings M, Lehrer EJ, Drabick JJ, Gusani NJ, Trifiletti DM, Zaorsky NG.

Am J Clin Oncol. 2019 Aug;42(8):624-635. doi: 10.1097/COC.0000000000000572.

PMID:
31313679
6.

Stereotactic ablative radiation therapy for oligometastatic renal cell carcinoma (SABR ORCA): a meta-analysis of 28 studies.

Zaorsky NG, Lehrer EJ, Kothari G, Louie AV, Siva S.

Eur Urol Oncol. 2019 Sep;2(5):515-523. doi: 10.1016/j.euo.2019.05.007. Epub 2019 Jul 11. Review.

PMID:
31302061
7.

The Emerging Role of Stereotactic Ablative Radiotherapy for Primary Renal Cell Carcinoma: A Systematic Review and Meta-Analysis.

Correa RJM, Louie AV, Zaorsky NG, Lehrer EJ, Ellis R, Ponsky L, Kaplan I, Mahadevan A, Chu W, Swaminath A, Hannan R, Onishi H, Teh BS, Muacevic A, Lo SS, Staehler M, Siva S.

Eur Urol Focus. 2019 Jun 24. pii: S2405-4569(19)30157-9. doi: 10.1016/j.euf.2019.06.002. [Epub ahead of print] Review.

PMID:
31248849
8.

The Influence of Online Forums on Radiation Oncology Residency Program Selection.

Malouff TD, Vallow LA, Waddle MR, Kaleem T, Zaorsky NG, Royce TJ, Stross WC, May B, Trifiletti DM.

Int J Radiat Oncol Biol Phys. 2019 Aug 1;104(5):1009-1011. doi: 10.1016/j.ijrobp.2019.04.011. Epub 2019 Apr 22. No abstract available.

PMID:
31022509
9.

Toxicity after radiotherapy in patients with historically accepted contraindications to treatment (CONTRAD): An international systematic review and meta-analysis.

Lin D, Lehrer EJ, Rosenberg J, Trifiletti DM, Zaorsky NG.

Radiother Oncol. 2019 Jun;135:147-152. doi: 10.1016/j.radonc.2019.03.006. Epub 2019 Mar 27. Review.

PMID:
31015161
10.

Suicide among cancer patients.

Zaorsky NG, Zhang Y, Tuanquin L, Bluethmann SM, Park HS, Chinchilli VM.

Nat Commun. 2019 Jan 14;10(1):207. doi: 10.1038/s41467-018-08170-1.

11.

Total skin electron beam therapy in mycosis fungoides-a shift towards lower dose?

Chowdhary M, Song A, Zaorsky NG, Shi W.

Chin Clin Oncol. 2019 Feb;8(1):9. doi: 10.21037/cco.2018.09.02. Epub 2018 Sep 17. Review.

13.

Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials.

Lehrer EJ, Peterson JL, Zaorsky NG, Brown PD, Sahgal A, Chiang VL, Chao ST, Sheehan JP, Trifiletti DM.

Int J Radiat Oncol Biol Phys. 2019 Mar 1;103(3):618-630. doi: 10.1016/j.ijrobp.2018.10.038. Epub 2018 Nov 2.

PMID:
30395902
14.

Stereotactic Radiosurgery and Immune Checkpoint Inhibitors in the Management of Brain Metastases.

Lehrer EJ, McGee HM, Peterson JL, Vallow L, Ruiz-Garcia H, Zaorsky NG, Sharma S, Trifiletti DM.

Int J Mol Sci. 2018 Oct 7;19(10). pii: E3054. doi: 10.3390/ijms19103054. Review.

15.

Treatment of brain metastases with stereotactic radiosurgery and immune checkpoint inhibitors: An international meta-analysis of individual patient data.

Lehrer EJ, Peterson J, Brown PD, Sheehan JP, Quiñones-Hinojosa A, Zaorsky NG, Trifiletti DM.

Radiother Oncol. 2019 Jan;130:104-112. doi: 10.1016/j.radonc.2018.08.025. Epub 2018 Sep 18. Review.

PMID:
30241791
16.

Industry Funding Is Correlated With Publication Productivity of US Academic Radiation Oncologists.

Zaorsky NG, Ahmed AA, Zhu J, Yoo SK, Fuller CD, Thomas CR Jr, Choi M, Holliday EB.

J Am Coll Radiol. 2019 Feb;16(2):244-251. doi: 10.1016/j.jacr.2018.07.024. Epub 2018 Sep 13.

PMID:
30219342
17.

Dose Escalation in Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Meta-Analysis.

Zaorsky NG, Lehrer EJ, Handorf E, Meyer JE.

Am J Clin Oncol. 2019 Jan;42(1):46-55. doi: 10.1097/COC.0000000000000472.

PMID:
29965809
18.

Ablative Hypofractionated Radiation Therapy Enhances Non-Small Cell Lung Cancer Cell Killing via Preferential Stimulation of Necroptosis In Vitro and In Vivo.

Wang HH, Wu ZQ, Qian D, Zaorsky NG, Qiu MH, Cheng JJ, Jiang C, Wang J, Zeng XL, Liu CL, Tian LJ, Ying GG, Meng MB, Hao XS, Yuan ZY.

Int J Radiat Oncol Biol Phys. 2018 May 1;101(1):49-62. doi: 10.1016/j.ijrobp.2018.01.036. Epub 2018 Jan 31.

PMID:
29619976
19.

Deviations From Standard Chemoradiation Among Early-Stage Anal Cancer Patients.

Churilla TM, DeMora L, Handorf E, Zaorsky NG, Dong Y, Denlinger CS, Sigurdson ER, Meyer JE.

Int J Radiat Oncol Biol Phys. 2018 Mar 15;100(4):945-949. doi: 10.1016/j.ijrobp.2017.12.003. Epub 2017 Dec 16. No abstract available.

PMID:
29485073
20.

Adult nodular lymphocyte-predominant Hodgkin lymphoma: treatment modality utilization and survival.

Alonso C, Dutta SW, Mitra N, Landsburg DJ, Zaorsky NG, Grover S, Peterson J, Trifiletti DM.

Cancer Med. 2018 Apr;7(4):1118-1126. doi: 10.1002/cam4.1383. Epub 2018 Feb 26.

Supplemental Content

Loading ...
Support Center